Skip to main content
Year archive

Vivoryon Therapeutics N.V. — 2021 filings

All 43 regulatory filings released by Vivoryon Therapeutics N.V. (VVY) in 2021, sourced directly from the official regulator.

43 Filings
2021 Period
2021 filings (43)
Filing Released Lang
Vivoryon Therapeutics Receives FDA Fast Track Designation for Varoglutamstat in Early Alzheimer's Disease
Regulatory Filings
2021-12-22 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Receives FDA Fast Track Designation for Varoglutamstat in Early Alzheimer's Disease (news with additional features)
Regulatory Filings
2021-12-22 English
Vivoryon Therapeutics N.V. Reports Q3 2021 Financial Results and Highlights Operational Progress
Interim / Quarterly Report 9M 2021
2021-11-04 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q3 2021 Financial Results and Highlights Operational Progress (news with additional features)
Interim / Quarterly Report 9M 2021
2021-11-04 English
Vivoryon Therapeutics N.V. to Report Third Quarter 2021 Financial Results on November 4, 2021
Report Publication Announcement
2021-11-01 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Report Third Quarter 2021 Financial Results on November 4, 2021
Report Publication Announcement
2021-11-01 English
Vivoryon Therapeutics Provides Update on Business and Progress of Varoglutamstat Clinical Development in Alzheimer’s Disease
Earnings Release Q4 2021
2021-10-18 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Provides Update on Business and Progress of Varoglutamstat Clinical Development in Alzheimer's Disease (news with additional features)
Earnings Release Q4 2021
2021-10-18 English
Vivoryon Therapeutics N.V. Reports H1 2021 Financial Results and Operational Progress
Earnings Release H1 2021
2021-09-21 English
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-09-21 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports H1 2021 Financial Results and Operational Progress (news with additional features)
Earnings Release H1 2021
2021-09-21 English
Vivoryon Therapeutics N.V. to Publish its Financial Results for H1 2021 and Operational Progress
Report Publication Announcement
2021-09-14 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Publish its Financial Results for H1 2021 and Operational Progress
Report Publication Announcement
2021-09-14 English
Vivoryon Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Regulatory Filings
2021-09-10 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Regulatory Filings
2021-09-09 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Provides Update on Financial Guidance
Regulatory Filings
2021-06-29 English
Vivoryon Therapeutics and Simcere Announce Strategic Regional Licensing Partnership to Develop and Commercialize N3pE Amyloid-targeting Medicines to Treat Alzheimer's Disease in Greater China
Regulatory Filings
2021-06-29 English
Ordinary General Meeting of Shareholders of Vivoryon Therapeutics N.V.
AGM Information
2021-06-29 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Provides Update on Financial Guidance
Earnings Release H1 2021
2021-06-29 English
Vivoryon Therapeutics and Simcere Announce Strategic Regional Licensing Partnership to Develop and Commercialize N3pE Amyloid-targeting Medicines to Treat Alzheimer's Disease in Greater China
M&A Activity
2021-06-29 English
Vivoryon Therapeutics N.V.: Ordinary General Meeting of Shareholders of Vivoryon Therapeutics N.V.
AGM Information
2021-06-28 English
Vivoryon Therapeutics Announces Financial Results for the First Quarter of 2021 and Provides Corporate Update
Earnings Release Q1 2021
2021-06-25 English
Vivoryon Therapeutics Announces Financial Results for the First Quarter of 2021 and Provides Corporate Update
Earnings Release Q1 2021
2021-06-25 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Financial Results for the First Quarter of 2021 and Provides Corporate Update
Earnings Release Q1 2021
2021-06-25 English
Vivoryon Therapeutics Reschedules Reporting of 1st Quarter 2021 and Provides Update for Annual General Meeting of Shareholders
Report Publication Announcement
2021-06-01 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Reschedules Reporting of 1st Quarter 2021 and Provides Update for Annual General Meeting of Shareholders
Report Publication Announcement
2021-05-31 English
Vivoryon Therapeutics Announces Notice of its Annual General Meeting of Shareholders to be Held on June 28, 2021
AGM Information
2021-05-17 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Notice of its Annual General Meeting of Shareholders to be Held on June 28, 2021
AGM Information
2021-05-17 English
Annual Report 2020
Annual Report FY 2020
2021-04-30 English
Vivoryon Therapeutics N.V. Reports Full Year 2020 Financial Results
Earnings Release FY 2020
2021-04-30 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Full Year 2020 Financial Results
Earnings Release FY 2020
2021-04-30 English
Vivoryon Therapeutics N.V. Reschedules the Reporting of the Full Year 2020 Financial Results to April 30, 2021
Report Publication Announcement
2021-04-14 English
Vivoryon Therapeutics N.V. Reschedules the Reporting of the Full Year 2020 Financial Results to April 30, 2021
Report Publication Announcement
2021-04-14 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reschedules the Reporting of the Full Year 2020 Financial Results to April 30, 2021
Report Publication Announcement
2021-04-14 English
Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscape in Alzheimer's Disease Treatment Options with Leaders and Experts on April 15th, 2021
Investor Presentation
2021-04-01 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscape in Alzheimer's Disease Treatment Options with Leaders and Experts on April 15th, 2021
Environmental & Social Information
2021-04-01 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscape in Alzheimer's Disease Treatment Options with Leaders and Experts on April 15th, 2021
Report Publication Announcement
2021-04-01 English
Extraordinary General Meeting of Shareholders of Vivoryon Therapeutics N.V.
AGM Information
2021-03-15 English
Vivoryon Therapeutics N.V.: Extraordinary General Meeting of Shareholders of Vivoryon Therapeutics N.V.
AGM Information
2021-03-12 English
Vivoryon Therapeutics N.V. Announces Nominations to Reappoint Ulrich Dauer as CEO and to Appoint Florian Schmid as CFO
Board/Management Information
2021-02-01 English
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Announces Nominations to Reappoint Ulrich Dauer as CEO and to Appoint Florian Schmid as CFO
Board/Management Information
2021-01-29 English
new ISIN code
Share Issue/Capital Change
2021-01-06 English
Vivoryon Therapeutics N.V. new ISIN code
Share Issue/Capital Change
2021-01-06 English